EU clears J&J’s Actelion buy, with conditions

12th June 2017 Uncategorised 0

The European Commission has issued a conditional green light for Johnson & Johnson’s planned $30 billion purchase of Actelion, laying out the commitments it feels are necessary to ensure that clinical development of the firms’ innovative insomnia drugs will not be adversely affected by the merger.

More: EU clears J&J’s Actelion buy, with conditions
Source: News